Insulet Gross Profit 2010-2025 | PODD
- Insulet gross profit for the quarter ending March 31, 2025 was $409M, a 33.31% increase year-over-year.
- Insulet gross profit for the twelve months ending March 31, 2025 was $1.548B, a 26.24% increase year-over-year.
- Insulet annual gross profit for 2024 was $1.446B, a 24.64% increase from 2023.
- Insulet annual gross profit for 2023 was $1.16B, a 43.98% increase from 2022.
- Insulet annual gross profit for 2022 was $0.806B, a 7.11% increase from 2021.
Insulet Annual Gross Profit (Millions of US $) |
|
---|---|
2024 | $1,446 |
2023 | $1,160 |
2022 | $806 |
2021 | $752 |
2020 | $582 |
2019 | $480 |
2018 | $370 |
2017 | $277 |
2016 | $211 |
2015 | $133 |
2014 | $127 |
2013 | $112 |
2012 | $92 |
2011 | $67 |
2010 | $44 |
2009 | $18 |
Insulet Quarterly Gross Profit (Millions of US $) |
|
---|---|
2025-03-31 | $409 |
2024-12-31 | $431 |
2024-09-30 | $377 |
2024-06-30 | $331 |
2024-03-31 | $307 |
2023-12-31 | $361 |
2023-09-30 | $293 |
2023-06-30 | $265 |
2023-03-31 | $241 |
2022-12-31 | $217 |
2022-09-30 | $188 |
2022-06-30 | $190 |
2022-03-31 | $210 |
2021-12-31 | $213 |
2021-09-30 | $189 |
2021-06-30 | $183 |
2021-03-31 | $168 |
2020-12-31 | $161 |
2020-09-30 | $152 |
2020-06-30 | $143 |
2020-03-31 | $127 |
2019-12-31 | $134 |
2019-09-30 | $123 |
2019-06-30 | $116 |
2019-03-31 | $107 |
2018-12-31 | $110 |
2018-09-30 | $102 |
2018-06-30 | $82 |
2018-03-31 | $76 |
2017-12-31 | $80 |
2017-09-30 | $74 |
2017-06-30 | $65 |
2017-03-31 | $59 |
2016-12-31 | $61 |
2016-09-30 | $56 |
2016-06-30 | $50 |
2016-03-31 | $44 |
2015-12-31 | $42 |
2015-09-30 | $32 |
2015-06-30 | $31 |
2015-03-31 | $29 |
2014-12-31 | $21 |
2014-09-30 | $38 |
2014-06-30 | $36 |
2014-03-31 | $33 |
2013-12-31 | $33 |
2013-09-30 | $27 |
2013-06-30 | $27 |
2013-03-31 | $25 |
2012-12-31 | $25 |
2012-09-30 | $24 |
2012-06-30 | $22 |
2012-03-31 | $20 |
2011-12-31 | $20 |
2011-09-30 | $19 |
2011-06-30 | $15 |
2011-03-31 | $14 |
2010-12-31 | $14 |
2010-09-30 | $12 |
2010-06-30 | $10 |
2010-03-31 | $8 |
2009-12-31 | $7 |
2009-09-30 | $6 |
2009-06-30 | $3 |
2009-03-31 | $2 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $20.867B | $2.072B |
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $232.025B | 27.90 |
Boston Scientific (BSX) | United States | $151.510B | 37.93 |
Stryker (SYK) | United States | $148.668B | 31.08 |
EssilorLuxottica (ESLOY) | France | $135.285B | 0.00 |
Medtronic (MDT) | Ireland | $113.608B | 16.10 |
Lonza Group Ag (LZAGY) | Switzerland | $50.270B | 0.00 |
Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
ResMed (RMD) | United States | $37.623B | 28.26 |
GE HealthCare Technologies (GEHC) | United States | $34.433B | 16.35 |
Agilent Technologies (A) | United States | $34.375B | 22.41 |
Terumo (TRUMY) | Japan | $24.785B | 32.19 |
Koninklijke Philips (PHG) | Netherlands | $23.187B | 16.27 |
Zimmer Biomet Holdings (ZBH) | United States | $18.493B | 11.88 |
Baxter (BAX) | United States | $15.734B | 11.75 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.038B | 0.00 |
Demant (WILYY) | Denmark | $8.971B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.823B | 23.74 |
Lantheus Holdings (LNTH) | United States | $5.702B | 14.38 |
Prestige Consumer Healthcare (PBH) | United States | $3.885B | 17.35 |
Perrigo (PRGO) | Ireland | $3.731B | 9.46 |
Haemonetics (HAE) | United States | $3.650B | 16.62 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.415B | 28.38 |
ICU Medical (ICUI) | United States | $3.262B | 24.05 |
QuidelOrtho (QDEL) | United States | $2.084B | 14.34 |
LeMaitre Vascular (LMAT) | United States | $1.896B | 42.38 |
AtriCure (ATRC) | United States | $1.566B | 0.00 |
Acuren (TIC) | United States | $1.379B | 0.00 |
AdaptHealth (AHCO) | United States | $1.286B | 13.06 |
Phibro Animal Health (PAHC) | United States | $1.221B | 15.61 |
Green Thumb Industries (GTBIF) | United States | $1.211B | 27.24 |
Neogen (NEOG) | United States | $1.137B | 14.56 |
BioLife Solutions (BLFS) | United States | $1.071B | 0.00 |
InMode (INMD) | Israel | $0.971B | 9.78 |
Kestra Medical Technologies (KMTS) | United States | $0.810B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
Owens & Minor (OMI) | United States | $0.695B | 5.76 |
Curaleaf Holdings (CURLF) | Canada | $0.643B | 0.00 |
CeriBell (CBLL) | United States | $0.619B | 0.00 |
Evolus (EOLS) | United States | $0.597B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.594B | 0.00 |
Valneva SE (VALN) | France | $0.497B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.465B | 0.00 |
Surmodics (SRDX) | United States | $0.429B | 0.00 |
SNDL (SNDL) | Canada | $0.363B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
Quanterix (QTRX) | United States | $0.327B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.322B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.299B | 0.00 |
Cerus (CERS) | United States | $0.279B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.277B | 23.40 |
Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
ZimVie (ZIMV) | United States | $0.268B | 12.19 |
Cresco Labs (CRLBF) | United States | $0.265B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.256B | 76.00 |
Brainsway (BWAY) | Israel | $0.243B | 64.35 |
OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
Biote (BTMD) | United States | $0.222B | 6.25 |
TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
Organigram Global (OGI) | Canada | $0.192B | 0.00 |
High Tide (HITI) | Canada | $0.190B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.187B | 15.23 |
Omeros (OMER) | United States | $0.183B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.181B | 0.00 |
Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
Exagen (XGN) | United States | $0.148B | 0.00 |
FitLife Brands (FTLF) | United States | $0.127B | 15.61 |
TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
Fonar (FONR) | United States | $0.097B | 12.47 |
MacroGenics (MGNX) | United States | $0.093B | 0.00 |
Jin Medical (ZJYL) | China | $0.091B | 0.00 |
Apyx Medical (APYX) | United States | $0.090B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
Veru (VERU) | United States | $0.085B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
Zynex (ZYXI) | United States | $0.073B | 0.00 |
InterCure (INCR) | Israel | $0.072B | 0.00 |
Agape ATP (ATPC) | $0.069B | 0.00 | |
Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
ImmuCell (ICCC) | United States | $0.060B | 0.00 |
Nephros (NEPH) | United States | $0.041B | 55.57 |
Modular Medical (MODD) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.84 |
Safety Shot (SHOT) | United States | $0.032B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Senestech (SNES) | United States | $0.011B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |